Updates and Information on Coronavirus (COVID-19)
Skip to content Skip to main navigation Report an accessibility issue

COVID-19 Funding Opportunities

Information about funding opportunities related to the novel coronavirus (COVID-19) will be added to this page as they become available. Please contact Kimberly Eck (avcrd@utk.edu) for more information or to report additional opportunities.

 

Deadline

Title

Funding Agency

More Information

Rolling Fast-Track Grant Response: COVID-19 Adira Foundation
June 2020 (anticipated) NOI: New Funding Opporutnity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsivenss to COVID-19 Agency for Healthcare Research and Quality
6/30/20 AWS Diagnostic Development Initiative (DDI) Amazon Web Services
Continuous submission Artist Relief Americans for the Arts
10/31/20 BAA; No limit to funding BARDA Highly recommended to schedule a TechWatch to brief BARDA POs
Continuous Submission Coronavirus Local Response Initiative Bloomberg Philanthropies
6/5/20 Innovation Fund Booz Allen Foundation Please contact Jill Passano at jpassano@utfi.org if you are interested in applying.
Open COVID-19 Collective Fund for Trans Communities Borealis Philanthropy
6/30/20 Rapid Development of Vaccines Against COVID-19 Coalition for Epidemic Preparedness Initiative (CEPI)
Continuous Submission Public Works and Economic Adjustment Assistance Programs DOC
Continuous Submission Dear Colleague Letter–Coronavirus Disease 2019 (COVID-19) DOE
Rolling Invitation for COVID-19 Scientific Questions DOE
Continuous Submission The COVID-19 High Performance Computing Consortium DOE
Rapid COVID-19 Research at the Spallation Neutron Source and High Flux Isotope Reactor DOE
Continuous Submission Fast Funding for COVID-19 Science Fast Grants
Rolling COVID-19 Telehealth Program FCC
8/31/20 Emergency Grants Foundation for Contemporary Arts
10/31/20 Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) HHS BARDA BAA Open ONLY to COVID-19 related projects. Please see full call for Techical Descriptions and agency personnel points of contact
Open COVID-19 Open Research Dataset Challenge (CORD-19) Kaggle
Pending OTA (Department of Defense) MCDC
5/31/20 Medical CBRN Defense Consortium (MCDC) Other Transaction Agreement (OTA) Request for Information (RFI) – CoV Pandemic Response Medical CBRN Defense Consortium (MCDC)
6/18/20 Health Security and Pandemics Challenge MIT Solve
Rolling COVID-19 Solutions Fund Mozilla Open Source Support Program (MOSS)
Pending OTA (Department of Defense); $40–60 million MTEC
Rolling COVID-19 Emergency Fund for Journalists National Geographic Society
9/4/20 NIH Director’s Emergency Early Independence Awards (DP5 Clinical Trial Optional) NIH / OSC If you are interested in applying, please contact Hannah Schmidt at hschmidt@utk.edu
9/30/20 NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional) NIH / OSC
6/29/20 RFA-AI-20-028 — Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) NIH
6/15/20 NIH / AHRQ
11/2/20 NOSI: Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR NIH / NIDCR
6/19/20 NOSI: Availability of Urgent Award for Competitive Revisions to IDeA-CTR Awards to Address the Need for Documenting 2019 Novel Coronavirus Disease (COVID-19)-Related Patient Outcomes NIH / NIGMS
4/1/21 NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences NIH / OBSSR
4/15/21 NOSI: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System NIH / NINDS
6/17/20 NOSI: Data Driven Research on Coronavirus Disease 2019 (COVID-19) (R21) NIH / NLM
10/6/20 NOSI: Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials NIH / NHLBI
4/16/21 NOSI: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA NIH / NIAAA
4/16/21 NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus NIH / NIMH
11/11/20 NOSI: Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs NIH / NCATS
Rolling Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) NIH / NIAID
Rolling NIH / NIAID
6/20/20 NOSI: Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NIH / Common Fund
5/1/21 NOSI: Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities NIH / NIMHD
6/16/20 Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trial Not Allowed) NIH
5/4/21 NOSI: NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) NIH / NIEHS
3/31/21 NOSI: Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) NIH / NIBIB
6/2/20 NOSI: Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK NIH / NIDDK
2/5/21 NOSI regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 NIH / NIGMS
3/25/21 NOSI regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NIH / NIAID
6/2/20 NOSI regarding the Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) NIH / NLM
10/5/20 NOSI: Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) NIH / NHLBI
Check with PO Administrative Supplements to Existing NIH Grants and Cooperative Agreements; No limit to funding NIH
6/29/20 Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed); $10 million NIH
3/31/21 NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus NIH / NIDA
5/1/21 NOSI: NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) NIH / NIA
Varies NOSI: Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) NIH / NCATS
10/6/20 NOSI: Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) NIH / NCCIH
Varies NOSI: Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need NIH
8/18/20 NOSI: Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19) NIH / NCCIH
6/2/20 NOSI regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) NIH / NCATS
6/26/20 NOSI: National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) NIH / NCI
9/8/21 NOSI: Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NIH / NIAID
Continuous Submission Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) NIH/DHHS
Rapid Proposals DCL on the Coronavirus Disease 2019 (COVID-19) NSF Please contact relevant program officer, or, rapid-covid19@nsf.gov.
Rapid Proposals DCL: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) NSF Please contact relevant program officer, or, rapid-covid19@nsf.gov.
6/4/20 DCL: Request for SBIR/STTR Phase I Proposals Addressing COVID-19 NSF
N/A Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations OMB
N/A Call to Action to the Tech Community on New Machine Readable COVID-19 Dataset Office of Science and Technology Policy
6/17/20 Vaccine Preventable Diseases – COVID-19 Pfizer
Continuous Submission COVID-19 Funding Phoenixville Community Health Foundation
Rolling Pioneering Ideas: Exploring the Future to Build a Culture of Health Robert Wood Johnson Foundation Please contact Jill Passano at jpassano@utfi.org if you are interested in applying.
6/10/20 Sustainability Grants South Arts
6/8/20 Research Grants on Education: COVID-19 Related Special Grant Cycle Spencer Foundation Please contact Jill Passano at jpassano@utfi.org if you are interested in applying.
9/1/20 Health Equity Breakthrough Team Research Grant Program Stand Up to Cancer
9/30/20 Medical Robotics for Contagious Diseases Challenge 2020 UK-RAS Network Robotics & Autonomous Systems
Continuous Submission Capital Region Community COVID-19 Response Fund United Way of the Greater Capital Region
6/30/20 The COVID-19 Detect & Protect Challenge United Nations Development Programme
6/4/20 AFRI: Rapid Response to Novel Coronavirus (SARS-CoV-2) Impacts Across Food and Agricultural Systems USDA

 

Other Resources

Ubermedia: COVID-19 Impact Research Resources